Health & Fitness
Health and Fitness
Health and Fitness
Mon, February 27, 2012
Sat, February 25, 2012
Fri, February 24, 2012
Perception, Opportunity in Volatility - Research &;; Analysis on VIVUS, Inc. and Arena Pharmaceuticals, Inc.
February 24, 2012 09:00 ET
Perception, Opportunity in Volatility - Research & Analysis on VIVUS, Inc. and Arena Pharmaceuticals, Inc.
HONG KONG--(Marketwire - Feb 24, 2012) - This morning, [ www.MarketFoundations.com ] announced new reports highlighting VIVUS, Inc. (
Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experienced in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.
Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.
Market Foundations is releasing new coverage on VIVUS, Inc. for its current position within the healthcare industry. VIVUS, Inc. is a biopharmaceutical company. The Company is engaged in development and commercialization of therapeutic drugs for large underserved markets, including obesity and related morbidities, such as sleep apnea and diabetes and men's sexual health. The full research report on VIVUS, Inc. (
Market Foundations has released research on Arena Pharmaceuticals, Inc. for its changing role within the healthcare industry. Arena Pharmaceuticals, Inc. (Arena) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. The full research report on Arena Pharmaceuticals, Inc. (
About Market Foundations
By providing members with financial information services, we provide the foundation investors need to build investing intelligence. The difference between consistently making good investments or bad investments is nothing more than the right information at the right time.
